Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US0396971071
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG001WH4DQ3
ARDX
Ardelyx Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Ardelyx Inc
ISIN
US0396971071
TICKER
ARDX
MIC
XNAS
REUTERS
ARDX.OQ
BLOOMBERG
ARDX US
Di., 03.11.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - November 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 03.11.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 02.11.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - November 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 02.11.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - November 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
So., 01.11.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - November 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
So., 01.11.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Sa., 31.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 31, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plai...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Sa., 31.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 30.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 30.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Do., 29.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 29, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 29.10.2026       Ardelyx
US0396971071

Alert: Claims focus on alleged misrepresentations about payer utilization management and prescription pull-through, which allegedly slowed new-patient starts for IBSRELA while Ardelyx reaffirmed $240 million to $250 million in 2025 sales guidance.NEW YORK, Oct. 29, 2026 /PRNewswire/ -- SueWallSt announces that a securities class action has been fi...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 29.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encour...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 29.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 28.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 28.10.2026       Ardelyx
US0396971071

Wall Street Reassessment: analysts repeatedly pressed Ardelyx on payer access and prior authorization hurdles, and the lawsuit contends management's reassurances supported continued sell-side expectations for approximately $1.75 billion in combined peak sales until ARDX fell 18% following the August 6, 2026 guidance announcement.NEW YORK, Oct. 28,...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 28.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 27.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 27.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 26.10.2026       Ardelyx
US0396971071

San Diego, California--(Newsfile Corp. - October 26, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or otherwise acquired Ardelyx, Inc. (NASDAQ: ARDX) common stock between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"). Ardelyx, Inc...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 26.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 26.10.2026       Ardelyx
US0396971071

LOS ANGELES, Oct. 26, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ: ARDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated there...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 26.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
So., 25.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Sa., 24.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 23.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 23, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 23.10.2026       Ardelyx
US0396971071

Real-world analysis showed serum phosphate reductions following XPHOZAH initiation across all phosphate binder groups evaluated...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 23.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 23.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 22.10.2026       Ardelyx
US0396971071

Regulatory Compliance Focus: The lawsuit contends Ardelyx assured the market it had confidently addressed a shifting Medicare reimbursement environment for XPHOZAH and IBSRELA, while payer utilization-management requirements were allegedly tightening behind the scenes.NEW YORK, Oct. 22, 2026 /PRNewswire/ -- SueWallSt notifies investors in Ardelyx,...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 22.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encoura...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 22.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 21.10.2026       Ardelyx
US0396971071

Important Notice Regarding Alleged Payer Access and Reimbursement Misrepresentations: the lawsuit contends Ardelyx pointed investors toward $1.75 billion in combined peak sales while payer utilization-management barriers were allegedly restricting patient starts for IBSRELA and XPHOZAH.NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Levi & Korsinsky,...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 21.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 21.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 21.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ: ARDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who pur...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mi., 21.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 20.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 20.10.2026       Ardelyx
US0396971071

Conference call scheduled for 4:30 p.m. Eastern Time  Conference call scheduled for 4:30 p.m. Eastern Time...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Di., 20.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plai...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 19.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 19.10.2026       Ardelyx
US0396971071

LOS ANGELES, Oct. 19, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ: ARDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated there...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Mo., 19.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
So., 18.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Sa., 17.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 16.10.2026       Ardelyx
US0396971071

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardelyx To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Ardelyx between January 13, 2025 and August 6, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 16.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ardelyx, Inc. (NASDAQ: ARDX) between January 13, 2025 and August 6, 2026, inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline.SO WHAT: If you purchased Ardelyx...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Fr., 16.10.2026       Ardelyx
US0396971071

New York, New York--(Newsfile Corp. - October 15, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the "Class Peri...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 15.10.2026       Ardelyx
US0396971071

Promise vs. Reality: Ardelyx pointed investors toward $1.75 billion in combined peak sales for IBSRELA and XPHOZAH, while the complaint alleges payer utilization-management barriers were already restricting patient access before the Company cut 2026 guidance and withdrew its long-term XPHOZAH target.NEW YORK, Oct. 15, 2026 /PRNewswire/ -- SueWallSt...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink
Do., 15.10.2026       Ardelyx
US0396971071

NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encourag...
Zur Nachricht
Ardelyx
Charts & Research Termsheets Terminal
Permalink